Press release
Eosinophilic Asthma Market Report Examines Leading Companies And Growth Opportunities
Eosinophilic Asthma Market
Forecasted Expansion of the Eosinophilic Asthma Market by 2030
The eosinophilic asthma market is projected to reach a value of $6.92 billion by 2030, growing at a strong compound annual growth rate (CAGR) of 16.9%. This impressive expansion is driven by advances in precision asthma treatments, a robust pipeline of biologic drugs, increasing use of biomarker-based diagnostics, personalized respiratory therapies, and the growth of specialized clinics. Throughout the forecast period, notable trends include greater adoption of biologic therapies, heightened focus on severe asthma phenotypes, rising demand for targeted immunotherapies, expansion of specialty respiratory centers, and initiatives aiming to reduce asthma exacerbation rates.
The eosinophilic asthma market size has grown rapidly in recent years. It will grow from $3.16 billion in 2025 to $3.71 billion in 2026 at a compound annual growth rate (CAGR) of 17.4%. The growth in the historic period can be attributed to poor response to inhaled steroids, asthma prevalence growth, eosinophil biomarker identification, hospital asthma admissions, chronic respiratory disease burden.
Download a free sample of the eosinophilic asthma market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21184&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR
Key Market Players Leading the Eosinophilic Asthma Industry
Several prominent companies dominate the eosinophilic asthma landscape, including Roche Holding AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Novartis AG, GSK plc, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Limited, Boehringer Ingelheim GmbH, Regeneron Pharmaceuticals Inc., Chiesi Farmaceutici S.p.A., Pfizer Inc., Merck & Co. Inc., Johnson & Johnson, Bayer AG, Eli Lilly and Company, AbbVie Inc., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Cipla Ltd., Sumitomo Dainippon Pharma Co. Ltd., Kyowa Kirin Co. Ltd., UCB S.A., 4D Pharma plc, MorphoSys AG, and Avalo Therapeutics Inc.
A significant move occurred in February 2024 when UK-based GSK plc acquired US biotechnology firm Aiolos Bio for $1 billion. This acquisition is intended to strengthen GSK's respiratory portfolio by expanding options for severe asthma patients with low T2 inflammation. Aiolos Bio specializes in developing treatments for respiratory and inflammatory diseases, including eosinophilic asthma, which positions GSK to enhance its leadership in respiratory care and broaden its patient reach.
View the full eosinophilic asthma market report:
https://www.thebusinessresearchcompany.com/report/eosinophilic-asthma-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR
Emerging Trends Shaping the Future of the Eosinophilic Asthma Market
Pharmaceutical companies are focusing heavily on creating innovative drugs that target specific immune pathways to effectively reduce inflammation and improve patient outcomes through personalized therapy. One key area of innovation involves monoclonal antibodies-laboratory-engineered molecules designed to mimic the immune system's ability to combat harmful pathogens. These antibodies are produced by fusing antibody-producing cells with cancer cells, enabling mass production of uniform antibodies.
For example, in August 2024, AstraZeneca plc announced that its monoclonal antibody treatment Fasenra received approval from China's National Medical Products Association for severe eosinophilic asthma. Fasenra is specifically designed for patients with elevated eosinophil levels, a condition that contributes to inflammation and worsened asthma symptoms. The drug works by targeting and depleting eosinophils via the IL-5 receptor, aiding the immune system in reducing these cells in blood and tissues. Its dosing schedule involves an initial loading phase with injections every four weeks for three doses, followed by maintenance doses every eight weeks.
Detailed Segmentation of the Global Eosinophilic Asthma Market
This report categorizes the eosinophilic asthma market according to disease type, treatment mode, end user, and further detailed subcategories.
1) By Disease Type:
- Severe Eosinophilic Asthma
- Mild to Moderate Eosinophilic Asthma
2) By Treatment Class:
- Biologics
- Bronchodilators
- Corticosteroids
- Immunomodulators
- Other Treatments
3) By End User:
- Hospitals
- Clinics
- Other End Users
Additional Subdivisions:
- Severe Eosinophilic Asthma is further divided into Refractory Eosinophilic Asthma and Late-Onset Eosinophilic Asthma.
- Mild to Moderate Eosinophilic Asthma includes Early-Onset Eosinophilic Asthma and Intermittent Eosinophilic Asthma.
This thorough segmentation offers a detailed perspective on the various disease manifestations, treatment options, and healthcare settings involved in managing eosinophilic asthma worldwide.
Key enhancements in our 2026 market reports include:
• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Eosinophilic Asthma Market Report Examines Leading Companies And Growth Opportunities here
News-ID: 4606475 • Views: …
More Releases from The Business Research Company
Digital Herd Immunization Passport Market Intelligence Report Covers Trends, Seg …
The digital herd immunization passport sector is poised for significant expansion in the coming years, reflecting growing global health and mobility needs. As technology advances and digital identity systems evolve, this market is set to become a critical component of health verification and travel processes worldwide. Let's explore the market's size, key players, emerging trends, and segmentation to understand its future trajectory.
Projected Market Size and Growth for Digital Herd Immunization…
Digital Healthcare Supply Chain Management Market Trends Support A 11.9% CAGR Ou …
The digital healthcare supply chain management sector is on the brink of significant expansion as healthcare systems worldwide increasingly embrace technology to optimize their supply chains. This market is set to transform how medical products and services are managed, driven by innovation and an escalating demand for efficiency and transparency. Below, we explore the market's size, key players, emerging trends, and segmentation to understand the landscape better.
Projected Growth and Market…
Digital Health Pass Market Report Examines Industry Trends, Growth Drivers And F …
The digital health pass sector is poised for remarkable expansion, as digital verification becomes more ingrained in everyday life beyond pandemic-related use. Advances in technology and growing demand for secure, interoperable health status systems are shaping this fast-evolving market. Let's explore the current market valuation projections, key players, emerging trends, and the detailed segmentation that define this promising industry.
Projected Market Size and Expected Growth of the Digital Health Pass Market…
Digital Health And Wellness Market Report Examines Leading Companies And Growth …
The digital health and wellness sector is set to experience remarkable expansion over the coming years, driven by rapid technological advancements and growing consumer demand for personalized healthcare solutions. As innovations continue to reshape how health is monitored and managed, this market is poised for substantial growth and transformation. Below, we explore the market size, key players, emerging trends, and critical segments shaping the digital health and wellness industry.
Projected Market…
More Releases for Eosinophilic
Eosinophilic Esophagitis Market to Surge to USD 4.1 Billion by 2034
Eosinophilic Esophagitis (EoE) is a chronic, immune-mediated inflammatory condition of the esophagus, characterized by eosinophil infiltration, difficulty swallowing, food impaction, and chest pain. Once considered rare, EoE has now emerged as one of the most common causes of dysphagia in children and adults, particularly in developed nations. Strong associations with allergic conditions such as asthma, eczema, and food allergies underscore its complex immunological nature.
Download Full PDF Sample Copy of Market…
Eosinophilic Asthma Treatment Market Outlook and Future Projections for 2030
The eosinophilic asthma treatment market represents a dynamic and continually evolving landscape, shaped by changing consumer demands and technological advancements. In this comprehensive report, we provide an in-depth exploration of the market, designed for a wide range of stakeholders including manufacturers, suppliers, distributors, and investors. Our goal is to equip industry participants with essential insights that enable informed decision-making in an ever-changing market environment. This analysis not only examines the…
Severe Eosinophilic Asthma Treatment Market Outlook and Future Projections for 2 …
The severe eosinophilic asthma treatment market represents a dynamic and continually evolving landscape, shaped by changing consumer demands and technological advancements. In this comprehensive report, we provide an in-depth exploration of the market, designed for a wide range of stakeholders including manufacturers, suppliers, distributors, and investors. Our goal is to equip industry participants with essential insights that enable informed decision-making in an ever-changing market environment. This analysis not only examines…
Eosinophilic Esophagitis Pipeline, Clinical Trials Assessment, Emerging Therapie …
DelveInsight's, "Eosinophilic Esophagitis Pipeline Insight" report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in Eosinophilic Esophagitis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore our latest breakthroughs in Eosinophilic Esophagitis research. Learn more about…
Severe Eosinophilic Asthma Treatment Market Outlook and Future Projections for 2 …
The severe eosinophilic asthma treatment market represents a dynamic and continually evolving landscape, shaped by changing consumer demands and technological advancements. In this comprehensive report, we provide an in-depth exploration of the market, designed for a wide range of stakeholders including manufacturers, suppliers, distributors, and investors. Our goal is to equip industry participants with essential insights that enable informed decision-making in an ever-changing market environment. This analysis not only examines…
Eosinophilic Granulomatosis Treatment Market Size and Overview Upto 2028|
The report comes out as an intelligent and thorough assessment tool as well as a great resource that will help you to secure a position of strength in the global Eosinophilic Granulomatosis Treatment market. It includes Porter's Five Forces and PESTLE analysis to equip your business with critical information and comparative data about the Global Eosinophilic Granulomatosis Treatment Market. We have provided a deep analysis of the vendor landscape to give…
